Literature DB >> 21406612

Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1.

Tak Yung Man1, Zoi Michailidou, Adnan Gokcel, Lynne Ramage, Karen E Chapman, Christopher J Kenyon, Jonathan R Seckl, Nicholas M Morton.   

Abstract

Increased dietary fat intake is associated with obesity, insulin resistance, and metabolic disease. In transgenic mice, adipose tissue-specific overexpression of the glucocorticoid-amplifying enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) exacerbates high-fat (HF) diet-induced visceral obesity and diabetes, whereas 11β-HSD1 gene knockout ameliorates this, favoring accumulation of fat in nonvisceral depots. Paradoxically, in normal mice HF diet-induced obesity (DIO) is associated with marked downregulation of adipose tissue 11β-HSD1 levels. To identify the specific dietary fats that regulate adipose 11β-HSD1 and thereby impact upon metabolic disease, we either fed mice diets enriched (45% calories as fat) in saturated (stearate), monounsaturated (oleate), or polyunsaturated (safflower oil) fats ad libitum or we pair fed them a low-fat (11%) control diet for 4 wk. Adipose and liver mass and glucocorticoid receptor and 11β-HSD1 mRNA and activity levels were determined. Stearate caused weight loss and hypoinsulinemia, partly due to malabsorption, and this markedly increased plasma corticosterone levels and adipose 11β-HSD1 activity. Oleate induced pronounced weight gain and hyperinsulinemia in association with markedly low plasma corticosterone and adipose 11β-HSD1 activity. Weight gain and hyperinsulinemia was less pronounced with safflower compared with oleate despite comparable suppression of plasma corticosterone and adipose 11β-HSD1. However, with pair feeding, safflower caused a selective reduction in visceral fat mass and relative insulin sensitization without affecting plasma corticosterone or adipose 11β-HSD1. The dynamic depot-selective relationship between adipose 11β-HSD1 and fat mass strongly implicates a dominant physiological role for local tissue glucocorticoid reactivation in fat mobilization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21406612      PMCID: PMC3605916          DOI: 10.1152/ajpendo.00531.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  55 in total

1.  Does central obesity reflect "Cushing's disease of the omentum"?

Authors:  I J Bujalska; S Kumar; P M Stewart
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

2.  Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats.

Authors:  D E Livingstone; G C Jones; K Smith; P M Jamieson; R Andrew; C J Kenyon; B R Walker
Journal:  Endocrinology       Date:  2000-02       Impact factor: 4.736

3.  Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.

Authors:  Nicholas M Morton; Janice M Paterson; Hiroaki Masuzaki; Megan C Holmes; Bart Staels; Catherine Fievet; Brian R Walker; Jeffrey S Flier; John J Mullins; Jonathan R Seckl
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

4.  Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes.

Authors:  Jonas Burén; Hui-Xia Liu; Jørgen Jensen; Jan W Eriksson
Journal:  Eur J Endocrinol       Date:  2002-03       Impact factor: 6.664

5.  Modulation of triglyceride metabolism by glucocorticoids in diet-induced obesity.

Authors:  L Mantha; E Palacios; Y Deshaies
Journal:  Am J Physiol       Date:  1999-08

6.  Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription.

Authors:  Li Feng Zhao; Yasumasa Iwasaki; Wang Zhe; Mitsuru Nishiyama; Takafumi Taguchi; Makoto Tsugita; Machiko Kambayashi; Kozo Hashimoto; Yoshio Terada
Journal:  Endocr J       Date:  2010-02-07       Impact factor: 2.349

7.  The regulation of lipoprotein lipase gene expression by dexamethasone in isolated rat adipocytes.

Authors:  J M Ong; R B Simsolo; B Saffari; P A Kern
Journal:  Endocrinology       Date:  1992-04       Impact factor: 4.736

8.  Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus.

Authors:  Christian Opherk; François Tronche; Christoph Kellendonk; Dirk Kohlmüller; Andreas Schulze; Wolfgang Schmid; Günther Schütz
Journal:  Mol Endocrinol       Date:  2004-03-18

9.  Blockade of the glucocorticoid receptor with RU 486: effects in vitro and in vivo on human adipose tissue lipoprotein lipase activity.

Authors:  M Ottosson; P Mårin; K Karason; A Elander; P Björntorp
Journal:  Obes Res       Date:  1995-05

10.  Peripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosterone.

Authors:  Zoi Michailidou; Anthony P Coll; Christopher J Kenyon; Nicholas M Morton; Stephen O'Rahilly; Jonathan R Seckl; Karen E Chapman
Journal:  J Endocrinol       Date:  2007-07       Impact factor: 4.286

View more
  9 in total

1.  Is 11β-HSD1 expressed in islet β-cells and regulated by corticotropin-releasing hormone?

Authors:  Jun-Li Liu; Coimbatore B Srikant; Subrata Chowdhury
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-09       Impact factor: 11.205

2.  Ginsenoside Rb1 increases insulin sensitivity through suppressing 11β-hydroxysteroid dehydrogenase type I.

Authors:  Bing Song; Li Ding; Haoqiang Zhang; Yafen Chu; Zhaohui Chang; Yali Yu; Dandan Guo; Shuping Zhang; Xuezheng Liu
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 3.  Overview of animal models of obesity.

Authors:  Thomas A Lutz; Stephen C Woods
Journal:  Curr Protoc Pharmacol       Date:  2012-09

4.  Regulation of 11β-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α.

Authors:  Jong Han Lee; Zhanguo Gao; Jianping Ye
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-19       Impact factor: 4.310

Review 5.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

6.  Effects of high fat feeding on liver gene expression in diabetic goto-kakizaki rats.

Authors:  Richard R Almon; Debra C Dubois; Siddharth Sukumaran; Xi Wang; Bai Xue; Jing Nie; William J Jusko
Journal:  Gene Regul Syst Bio       Date:  2012-11-28

7.  Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP.

Authors:  Cristina L Esteves; Val Kelly; Valérie Bégay; Tak Y Man; Nicholas M Morton; Achim Leutz; Jonathan R Seckl; Karen E Chapman
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

8.  Decreased 11β-Hydroxysteroid Dehydrogenase 1 Level and Activity in Murine Pancreatic Islets Caused by Insulin-Like Growth Factor I Overexpression.

Authors:  Subrata Chowdhury; Larson Grimm; Ying Jia Kate Gong; Beixi Wang; Bing Li; Coimbatore B Srikant; Zu-hua Gao; Jun-Li Liu
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

9.  Neonatal overfeeding induced glucocorticoid overexposure accelerates hepatic lipogenesis in male rats.

Authors:  Fan Yang; Yanyan Dai; Cuiting Min; Xiaonan Li
Journal:  Nutr Metab (Lond)       Date:  2018-05-02       Impact factor: 4.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.